nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoteridol—Rash maculo-papular—Epirubicin—peripheral nervous system neoplasm	0.00215	0.00215	CcSEcCtD
Gadoteridol—Pain—Melphalan—peripheral nervous system neoplasm	0.00215	0.00215	CcSEcCtD
Gadoteridol—Flushing—Cisplatin—peripheral nervous system neoplasm	0.00215	0.00215	CcSEcCtD
Gadoteridol—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00214	0.00214	CcSEcCtD
Gadoteridol—Malaise—Alitretinoin—peripheral nervous system neoplasm	0.00213	0.00213	CcSEcCtD
Gadoteridol—Salivary hypersecretion—Doxorubicin—peripheral nervous system neoplasm	0.00213	0.00213	CcSEcCtD
Gadoteridol—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.00212	0.00212	CcSEcCtD
Gadoteridol—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00211	0.00211	CcSEcCtD
Gadoteridol—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.0021	0.0021	CcSEcCtD
Gadoteridol—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.0021	0.0021	CcSEcCtD
Gadoteridol—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.00208	0.00208	CcSEcCtD
Gadoteridol—Fluid retention—Doxorubicin—peripheral nervous system neoplasm	0.00208	0.00208	CcSEcCtD
Gadoteridol—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.00208	0.00208	CcSEcCtD
Gadoteridol—Cough—Alitretinoin—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Gadoteridol—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Gadoteridol—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00204	0.00204	CcSEcCtD
Gadoteridol—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00204	0.00204	CcSEcCtD
Gadoteridol—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00203	0.00203	CcSEcCtD
Gadoteridol—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00203	0.00203	CcSEcCtD
Gadoteridol—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00202	0.00202	CcSEcCtD
Gadoteridol—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00202	0.00202	CcSEcCtD
Gadoteridol—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00201	0.00201	CcSEcCtD
Gadoteridol—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.00201	0.00201	CcSEcCtD
Gadoteridol—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00201	0.00201	CcSEcCtD
Gadoteridol—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00201	0.00201	CcSEcCtD
Gadoteridol—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00201	0.00201	CcSEcCtD
Gadoteridol—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00201	0.00201	CcSEcCtD
Gadoteridol—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.002	0.002	CcSEcCtD
Gadoteridol—Urticaria—Melphalan—peripheral nervous system neoplasm	0.002	0.002	CcSEcCtD
Gadoteridol—Rash maculo-papular—Doxorubicin—peripheral nervous system neoplasm	0.00199	0.00199	CcSEcCtD
Gadoteridol—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00199	0.00199	CcSEcCtD
Gadoteridol—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Gadoteridol—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Gadoteridol—Flushing—Etoposide—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Gadoteridol—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Gadoteridol—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00193	0.00193	CcSEcCtD
Gadoteridol—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.00193	0.00193	CcSEcCtD
Gadoteridol—Shock—Alitretinoin—peripheral nervous system neoplasm	0.0019	0.0019	CcSEcCtD
Gadoteridol—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00189	0.00189	CcSEcCtD
Gadoteridol—Tremor—Cisplatin—peripheral nervous system neoplasm	0.00189	0.00189	CcSEcCtD
Gadoteridol—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00187	0.00187	CcSEcCtD
Gadoteridol—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00187	0.00187	CcSEcCtD
Gadoteridol—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.00187	0.00187	CcSEcCtD
Gadoteridol—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00186	0.00186	CcSEcCtD
Gadoteridol—Oedema—Vincristine—peripheral nervous system neoplasm	0.00186	0.00186	CcSEcCtD
Gadoteridol—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00186	0.00186	CcSEcCtD
Gadoteridol—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00185	0.00185	CcSEcCtD
Gadoteridol—Malaise—Cisplatin—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Gadoteridol—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00181	0.00181	CcSEcCtD
Gadoteridol—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.00181	0.00181	CcSEcCtD
Gadoteridol—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.0018	0.0018	CcSEcCtD
Gadoteridol—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.0018	0.0018	CcSEcCtD
Gadoteridol—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.0018	0.0018	CcSEcCtD
Gadoteridol—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.0018	0.0018	CcSEcCtD
Gadoteridol—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00178	0.00178	CcSEcCtD
Gadoteridol—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00178	0.00178	CcSEcCtD
Gadoteridol—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Gadoteridol—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00175	0.00175	CcSEcCtD
Gadoteridol—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00174	0.00174	CcSEcCtD
Gadoteridol—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00174	0.00174	CcSEcCtD
Gadoteridol—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00174	0.00174	CcSEcCtD
Gadoteridol—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00174	0.00174	CcSEcCtD
Gadoteridol—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00173	0.00173	CcSEcCtD
Gadoteridol—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00172	0.00172	CcSEcCtD
Gadoteridol—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00172	0.00172	CcSEcCtD
Gadoteridol—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00171	0.00171	CcSEcCtD
Gadoteridol—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00171	0.00171	CcSEcCtD
Gadoteridol—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00171	0.00171	CcSEcCtD
Gadoteridol—Dizziness—Topotecan—peripheral nervous system neoplasm	0.0017	0.0017	CcSEcCtD
Gadoteridol—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00169	0.00169	CcSEcCtD
Gadoteridol—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00168	0.00168	CcSEcCtD
Gadoteridol—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00168	0.00168	CcSEcCtD
Gadoteridol—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00167	0.00167	CcSEcCtD
Gadoteridol—Malaise—Etoposide—peripheral nervous system neoplasm	0.00166	0.00166	CcSEcCtD
Gadoteridol—Face oedema—Epirubicin—peripheral nervous system neoplasm	0.00166	0.00166	CcSEcCtD
Gadoteridol—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00165	0.00165	CcSEcCtD
Gadoteridol—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00164	0.00164	CcSEcCtD
Gadoteridol—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00164	0.00164	CcSEcCtD
Gadoteridol—Oedema—Cisplatin—peripheral nervous system neoplasm	0.00164	0.00164	CcSEcCtD
Gadoteridol—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00164	0.00164	CcSEcCtD
Gadoteridol—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.00164	0.00164	CcSEcCtD
Gadoteridol—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.00163	0.00163	CcSEcCtD
Gadoteridol—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00163	0.00163	CcSEcCtD
Gadoteridol—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.00162	0.00162	CcSEcCtD
Gadoteridol—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00162	0.00162	CcSEcCtD
Gadoteridol—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00162	0.00162	CcSEcCtD
Gadoteridol—Rash—Topotecan—peripheral nervous system neoplasm	0.00162	0.00162	CcSEcCtD
Gadoteridol—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00162	0.00162	CcSEcCtD
Gadoteridol—Cough—Etoposide—peripheral nervous system neoplasm	0.00161	0.00161	CcSEcCtD
Gadoteridol—Headache—Topotecan—peripheral nervous system neoplasm	0.00161	0.00161	CcSEcCtD
Gadoteridol—Rash—Tretinoin—peripheral nervous system neoplasm	0.0016	0.0016	CcSEcCtD
Gadoteridol—Rash—Isotretinoin—peripheral nervous system neoplasm	0.0016	0.0016	CcSEcCtD
Gadoteridol—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.0016	0.0016	CcSEcCtD
Gadoteridol—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.0016	0.0016	CcSEcCtD
Gadoteridol—Convulsion—Etoposide—peripheral nervous system neoplasm	0.0016	0.0016	CcSEcCtD
Gadoteridol—Vomiting—Melphalan—peripheral nervous system neoplasm	0.0016	0.0016	CcSEcCtD
Gadoteridol—Headache—Tretinoin—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Gadoteridol—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Gadoteridol—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Gadoteridol—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Gadoteridol—Pain—Vincristine—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Gadoteridol—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Gadoteridol—Rash—Melphalan—peripheral nervous system neoplasm	0.00158	0.00158	CcSEcCtD
Gadoteridol—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00158	0.00158	CcSEcCtD
Gadoteridol—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00157	0.00157	CcSEcCtD
Gadoteridol—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00155	0.00155	CcSEcCtD
Gadoteridol—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00154	0.00154	CcSEcCtD
Gadoteridol—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Gadoteridol—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Gadoteridol—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Gadoteridol—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Gadoteridol—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Gadoteridol—Nausea—Topotecan—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Gadoteridol—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00151	0.00151	CcSEcCtD
Gadoteridol—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00151	0.00151	CcSEcCtD
Gadoteridol—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.00151	0.00151	CcSEcCtD
Gadoteridol—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00151	0.00151	CcSEcCtD
Gadoteridol—Nausea—Melphalan—peripheral nervous system neoplasm	0.00149	0.00149	CcSEcCtD
Gadoteridol—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.00148	0.00148	CcSEcCtD
Gadoteridol—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00148	0.00148	CcSEcCtD
Gadoteridol—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00147	0.00147	CcSEcCtD
Gadoteridol—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00147	0.00147	CcSEcCtD
Gadoteridol—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00146	0.00146	CcSEcCtD
Gadoteridol—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00146	0.00146	CcSEcCtD
Gadoteridol—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00142	0.00142	CcSEcCtD
Gadoteridol—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00142	0.00142	CcSEcCtD
Gadoteridol—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Gadoteridol—Pain—Cisplatin—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Gadoteridol—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Gadoteridol—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Gadoteridol—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00136	0.00136	CcSEcCtD
Gadoteridol—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Gadoteridol—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Gadoteridol—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00134	0.00134	CcSEcCtD
Gadoteridol—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Gadoteridol—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Gadoteridol—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00131	0.00131	CcSEcCtD
Gadoteridol—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Gadoteridol—Pain—Etoposide—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Gadoteridol—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Gadoteridol—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Gadoteridol—Sweating—Epirubicin—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Gadoteridol—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Gadoteridol—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Gadoteridol—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00123	0.00123	CcSEcCtD
Gadoteridol—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00123	0.00123	CcSEcCtD
Gadoteridol—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Gadoteridol—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Gadoteridol—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Gadoteridol—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Gadoteridol—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Gadoteridol—Urticaria—Etoposide—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Gadoteridol—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Gadoteridol—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Gadoteridol—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Gadoteridol—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Gadoteridol—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Gadoteridol—Rash—Vincristine—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Gadoteridol—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Gadoteridol—Headache—Vincristine—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Gadoteridol—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Gadoteridol—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Gadoteridol—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Gadoteridol—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Gadoteridol—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Gadoteridol—Nausea—Vincristine—peripheral nervous system neoplasm	0.0011	0.0011	CcSEcCtD
Gadoteridol—Flushing—Epirubicin—peripheral nervous system neoplasm	0.0011	0.0011	CcSEcCtD
Gadoteridol—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.0011	0.0011	CcSEcCtD
Gadoteridol—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Gadoteridol—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Gadoteridol—Rash—Cisplatin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Gadoteridol—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Gadoteridol—Erythema—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Gadoteridol—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Gadoteridol—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Gadoteridol—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Gadoteridol—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Gadoteridol—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000995	0.000995	CcSEcCtD
Gadoteridol—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000976	0.000976	CcSEcCtD
Gadoteridol—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000959	0.000959	CcSEcCtD
Gadoteridol—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000957	0.000957	CcSEcCtD
Gadoteridol—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000957	0.000957	CcSEcCtD
Gadoteridol—Rash—Etoposide—peripheral nervous system neoplasm	0.000949	0.000949	CcSEcCtD
Gadoteridol—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000948	0.000948	CcSEcCtD
Gadoteridol—Headache—Etoposide—peripheral nervous system neoplasm	0.000943	0.000943	CcSEcCtD
Gadoteridol—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000937	0.000937	CcSEcCtD
Gadoteridol—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000932	0.000932	CcSEcCtD
Gadoteridol—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000927	0.000927	CcSEcCtD
Gadoteridol—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000909	0.000909	CcSEcCtD
Gadoteridol—Cough—Epirubicin—peripheral nervous system neoplasm	0.000902	0.000902	CcSEcCtD
Gadoteridol—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000896	0.000896	CcSEcCtD
Gadoteridol—Nausea—Etoposide—peripheral nervous system neoplasm	0.000894	0.000894	CcSEcCtD
Gadoteridol—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000893	0.000893	CcSEcCtD
Gadoteridol—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000888	0.000888	CcSEcCtD
Gadoteridol—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.00088	0.00088	CcSEcCtD
Gadoteridol—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000877	0.000877	CcSEcCtD
Gadoteridol—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.00087	0.00087	CcSEcCtD
Gadoteridol—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000863	0.000863	CcSEcCtD
Gadoteridol—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000861	0.000861	CcSEcCtD
Gadoteridol—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000858	0.000858	CcSEcCtD
Gadoteridol—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000844	0.000844	CcSEcCtD
Gadoteridol—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000844	0.000844	CcSEcCtD
Gadoteridol—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000841	0.000841	CcSEcCtD
Gadoteridol—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000835	0.000835	CcSEcCtD
Gadoteridol—Shock—Epirubicin—peripheral nervous system neoplasm	0.00083	0.00083	CcSEcCtD
Gadoteridol—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000829	0.000829	CcSEcCtD
Gadoteridol—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000826	0.000826	CcSEcCtD
Gadoteridol—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000816	0.000816	CcSEcCtD
Gadoteridol—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000814	0.000814	CcSEcCtD
Gadoteridol—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000812	0.000812	CcSEcCtD
Gadoteridol—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000805	0.000805	CcSEcCtD
Gadoteridol—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000796	0.000796	CcSEcCtD
Gadoteridol—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000788	0.000788	CcSEcCtD
Gadoteridol—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000781	0.000781	CcSEcCtD
Gadoteridol—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000781	0.000781	CcSEcCtD
Gadoteridol—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000768	0.000768	CcSEcCtD
Gadoteridol—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000758	0.000758	CcSEcCtD
Gadoteridol—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000755	0.000755	CcSEcCtD
Gadoteridol—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000752	0.000752	CcSEcCtD
Gadoteridol—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00073	0.00073	CcSEcCtD
Gadoteridol—Pain—Epirubicin—peripheral nervous system neoplasm	0.000722	0.000722	CcSEcCtD
Gadoteridol—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000701	0.000701	CcSEcCtD
Gadoteridol—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000696	0.000696	CcSEcCtD
Gadoteridol—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000695	0.000695	CcSEcCtD
Gadoteridol—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.00067	0.00067	CcSEcCtD
Gadoteridol—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000668	0.000668	CcSEcCtD
Gadoteridol—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000667	0.000667	CcSEcCtD
Gadoteridol—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000667	0.000667	CcSEcCtD
Gadoteridol—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000643	0.000643	CcSEcCtD
Gadoteridol—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000622	0.000622	CcSEcCtD
Gadoteridol—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00062	0.00062	CcSEcCtD
Gadoteridol—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000617	0.000617	CcSEcCtD
Gadoteridol—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000617	0.000617	CcSEcCtD
Gadoteridol—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000597	0.000597	CcSEcCtD
Gadoteridol—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000577	0.000577	CcSEcCtD
Gadoteridol—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000575	0.000575	CcSEcCtD
Gadoteridol—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000558	0.000558	CcSEcCtD
Gadoteridol—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000552	0.000552	CcSEcCtD
Gadoteridol—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000536	0.000536	CcSEcCtD
Gadoteridol—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000534	0.000534	CcSEcCtD
Gadoteridol—Rash—Epirubicin—peripheral nervous system neoplasm	0.000532	0.000532	CcSEcCtD
Gadoteridol—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000532	0.000532	CcSEcCtD
Gadoteridol—Headache—Epirubicin—peripheral nervous system neoplasm	0.000529	0.000529	CcSEcCtD
Gadoteridol—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000516	0.000516	CcSEcCtD
Gadoteridol—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000501	0.000501	CcSEcCtD
Gadoteridol—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000496	0.000496	CcSEcCtD
Gadoteridol—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000492	0.000492	CcSEcCtD
Gadoteridol—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000492	0.000492	CcSEcCtD
Gadoteridol—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000489	0.000489	CcSEcCtD
Gadoteridol—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000464	0.000464	CcSEcCtD
